Titan Pharma (TTNP) Misses Q4 EPS by 1c

Titan Pharma (NASDAQ: TTNP) reported Q4 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Titan Pharma (TTNP) click here.

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• Premarket movers: Crypto stocks rally, Ross Stores jump on upbeat forecast
• Zurn Water Solutions (ZWS) Reiterated at Buy by Stifel on New Product Development Momentum